Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia

Civeira, Fernando·2004·Atherosclerosis
DOI 10.1016/j.atherosclerosis.2003.11.010

Cited by (496)

Items 401–496 of 496

  1. Complicated Treatment Course of Severe Asymptomatic Hypertriglyceridemia: A Case Report and Literature Review
    Ahmad Haddad, Mohammad Kloub, Wassim Abouzeid, Muhammad Hussain, Deema Haddad, Atheer Anwar, Qusai Al-maharmeh · 2024 · American Journal of Case Reports
  2. An abundance of population-specific monomorphic SNPs may or may not be meaningful: a commentary on differences in allele frequencies of familial hypercholesterolemia SNPs in the Malaysian population
    Wanna Thongnoppakhun, Anunchai Assawamakin, Sissades Tongsima · 2012 · Journal of Human Genetics
  3. Familial Hypercholesterolemia with Tendinous Xanthomas and Achilles Tendinitis – A Forgotten Dermato-Rheumatologic Association
    Puspanjuli Sahu, Saritha Mohanan, Carounanidy Udayshankar, Sankappa Pundalikappa Sinhasan, Ramachandra V Bhat · 2019 · Serbian Journal of Dermatology and Venerology
  4. Population-based screening in children for early diagnosis and treatment of familial hypercholesterolemia: design of the VRONI study
    Veronika Sanin, Raphael S. Schmieder, Sara Ates, Lea D. Schlieben, Jens Wiehler, Ruoyu Sun, Manuela Decker, Michaela Sander, Stefan Holdenrieder, Florian Kohlmayer et al. · 2022 · Medizinische Genetik
  5. Effects of Smad decoy ODN on shear stress-induced atherosclerotic ApoE-/-mouse.
    Hyun‐Jin An, Woo‐Ram Lee, Kyung‐Hyun Kim, Jung‐Yeon Kim, Woon‐Hae Kim, Kwan‐Kyu Park, Sung Won Youn · 2015 · Europe PMC (PubMed Central)
  6. Sobreexpresión génica de citocinas proinflamatorias en macrófagos de sujetos con hipercolesterolemia familiar y xantomas tendinosos
    Paula Martín‐Fuentes, Fernando Civeira, María Solanas-Barca, Estíbaliz Jarauta, A.L. García-Otín, Pilar Calmarza, Ana Cenarro · 2008 · Clínica e Investigación en Arteriosclerosis
  7. Efecto del polimorfismo C54Y del gen del transportador ABCG8 en los valores de cHDL en pacientes con hipercolesterolemia familiar
    Francisco J. Fuentes, José López‐Miranda, Amelia García, Montserrat Cofán, Juan Antonio Moreno, Rafael Moreno‐Luna, Javier Caballero‐Villarraso, Emilio Ros, Francisco Pérez‐Jiménez · 2006 · Clínica e Investigación en Arteriosclerosis
  8. Efectividad de un programa de prevención secundaria de la arteriosclerosis en el control de las dislipemias en pacientes con enfermedad arterial coronaria
    José Félix Meco López, Emili Corbella Inglés, Carmen Sanclemente Anso, Marta Miralles Fortuny, I. Sarasa corral, Ramón Pujol Farriols, Xavier Pintó · 2006 · Clínica e Investigación en Arteriosclerosis
  9. Diet and Lipid Profile of Vegetarians and Non-Vegetarians in Some Selected Communities in Accra
    Cedell Naa Oblikai Tetteh · 2013
  10. Living with genetic risk of coronary heart disease : a qualitative interview study of patients with familial hypercholesterolemia
    Jan C. Frich · 2007 · Duo Research Archive (University of Oslo)
  11. Familial hypercholesterolemia: bridging and minding the gap in healthcare
    Jing Pang, Alistair W. Vickery, Gerald Francis Watts · 2013
  12. New Treatments on the Horizon for Familial Hypercholesterolemia
    Khalid Al‐Rasadi, Khalid Al-Waili · 2017 · Oman Medical Journal
  13. Classification of Hyperlipidemias and Dyslipidemias
    Jesús E. Millán Núñez-Cortes, Joaquín J. Millán Pérez · 2018 · Elsevier eBooks
  14. Current Causes of Death in Familial Hypercholesterolemia
    Victoria Marco Benedi, Ana M. Bea, Ana Cenarro, Estíbaliz Jarauta, Martín Laclaustra, Fernando Civeira · 2021 · Research Square
  15. Familial Hypercholesterolemia
    Ashish Sarraju, Joshua W. Knowles · 2019 · Cardiac and vascular biology
  16. Familiäre Hypercholesterinämie bei Kindern und Jugendlichen
    S. Dietrich, M. Miklautsch, K. Widhalm · 2008 · Monatsschrift Kinderheilkunde
  17. Aterosclerosis subclínica medida mediante el grosor íntima-media carotídeo en hiperlipemias primarias
    Estíbaliz Jarauta Simón, Fernando Civeira Murillo · 2011 · Dialnet (Universidad de la Rioja)
  18. Efeitos de hipolipemiantes e polimorfismos sobre a expressão dos genes HMGCR, LDLR, SREBF1a, SREBF2, SCAP e NPC1L1 em indivíduos hipercolesterolêmicos.
    Simone Sorkin Arazi · 2008
  19. Familial Dyslipidemias: From Genetics to Clinical Picture
    Paolo Rubba, Marco Gentile, Salvatore Panico, Paolo Pauciullo · 2011
  20. MOLECULAR CHARACTERIZATION AND SPECTRUM OF MUTATIONS ASSOCIATED WITH AUTOSOMAL DOMINANT HYPERCHOLESTEROLEMIA
    Maria Nicoletta D’Agostino · 2014
  21. Manejo terap?utico de la arteriosclerosis
    Pedro Valdivielso Felices, C. Garca Arias, MA Sánchez Chaparro, P. Gonzlez Santos · 2005 · Medicine - Programa de Formación Médica Continuada Acreditado
  22. Aortic valve involvement and premature coronary artery disease in Heterozygous Familial Hypercholesterolemia
    Musa Şahin, Hakkı Şimşek, Mustafa Tuncer, Hasan Ali Gümrükçüoğlu, Beyhan Eryonucu · 2011 · Journal of Clinical and Experimental Investigations
  23. "Avaliação de parâmetros clínicos e nutricionais em pacientes com hipercolesterolemia familiar heterozigótica"
    Alessandra Alaniz Macedo · 2006
  24. La pravastatina es eficaz en la reducción de la progresión aterosclerótica en niños con hipercolesterolemia familiar heterocigota, sin afectar al crecimiento y el desarrollo
    Ana Espínola · 2004 · FMC - Formación Médica Continuada en Atención Primaria
  25. El grosor íntimo-medial carotídeo y su utilidad actual
    Antonio Luis Aguilar-Shea, Cristina Gallardo-Mayo, Elpidio Calvo Manuel, José Luis Zamorano Gómez · 2010 · Atención Primaria
  26. Hypercholestérolémie de l’enfant : quand traiter ?
    J.-P. Girardet · 2012 · Médecine des Maladies Métaboliques
  27. Exploring the impact of DNA testing for familial hypercholesterolaemia
    Melanie Watson · 2010 · British Journal of Cardiac Nursing
  28. Protocolo diagnóstico de hipercolesterolemias
    Miguel Pocoví Mieras, P. Mata López, Pedro Gómez · 2004 · Medicine - Programa de Formación Médica Continuada Acreditado
  29. ¿Hasta dónde hay que reducir el colesterol en el paciente de alto riesgo cardiovascular?
    Pedro Armario, R. Hernández del Rey, M.N. Görbig Romeu · 2005 · Hipertensión y Riesgo Vascular
  30. Protocolo terapéutico de las dislipidemias
    Fernando Civeira Murillo, R. Mateo Gallego · 2013 · Medicine - Programa de Formación Médica Continuada Acreditado
  31. Into the wardrobe of Narnia: beyond HIV infection a world of cardiovascular risk
    Marco Colotto, Alessandra Renzi, Cosimo Durante · 2012 · BMJ Case Reports
  32. Introducción a la genética y su utilidad en el diagnóstico de las enfermedades cardiovasculares: conceptos básicos y el ejemplo de la hipercolesterolemia familiar
    Fernando Civeira, José Carlos Rodríguez-Rey, Miguel Pocovı́ · 2009 · Revista Española de Cardiología Suplementos
  33. Diagnóstico y tratamiento de la hipercolesterolemia familiar
    Pilar Gómez Enterría, Ceferino Martinez Faedo · 2007 · Endocrinología y Nutrición
  34. Dislipidemias aterogénicas. Concepto. Mecanismos etiopatogénicos. Manifestaciones clínicas. Historia natural. Desarrollo de complicaciones. Criterios de sospecha, diagnósticos y pronósticos
    Jacinto Fernández Pardo, C. Royo-Villanova, M. Giménez Bello, C. Vera Sánchez-Rojas · 2009 · Medicine - Programa de Formación Médica Continuada Acreditado
  35. Hipercolesterolemia y deterioro cognitivo
    Jesús Millán Núñez-Cortés · 2012 · Clínica e Investigación en Arteriosclerosis
  36. Avaliação da aterosclerose subclínica coronariana e carotídea em portadores de hipercolesterolemia familiar: análise pela angiotomografia coronária, rigidez arterial e espessura íntima-média carotídea
    Marcio Hiroshi Miname · 2010
  37. Risk Factors Affecting the Phenotypic Expression of Heterozygous Familial Hypercholesterolemia in Pakistani Population
    Fauzia Imtiaz, Wajahatullah Khan, Ahsan A. Vahidy · 2017 · Atlas Journal of Biology
  38. Geneetilistel markeritel põhinev südame isheemiatõve riski hindamine Eesti Geenivaramu kohordis
    Anett Tähiste · 2014 · DSpace repository (University of Tartu)
  39. Mujer de 39 a?os con s?ndrome coronario agudo
    J.F. Meco Lpez, X. Pint Sala · 2005 · Medicine - Programa de Formación Médica Continuada Acreditado
  40. The susceptibility to metabolic and proliferative diseases - from genetic predisposition to treatment
    Cristina Maglio · 2014 · Gothenburg University Publications Electronic Archive (Gothenburg University)
  41. Aplicación de la secuenciación masiva de nueva generación al diagnóstico molecular de la hipercolesterolemia familiar
    Estefanía Martinez-Barrios, Ana Isabel Martínez-Puchol, Alba Roset, Daniel Zambón, Joan Clària, Montserrat Bernat · 2015 · Revista del Laboratorio Clínico
  42. Using a Temperature Gradient against the Time in Polyacrylamide Gel Electrophoresis May Eliminate the Need for Stacking Gels
    Pezhman Fard‐Esfahani, Peyman Mohammadi Torbati, Shahid Beheshti · 2009 · Iranian journal of pathology
  43. Metabolismo de quilomícrons e aterosclerose subclínica em portadores de hipercolesterolemia familiar heterozigótica
    Márcia Maria Carneiro · 2011
  44. Pharmacokinetics, efficacy, and safety of pravastatin in children
    Mia Koskinen · 2006
  45. Comparison of classical and probable heterozygousfamilial hypercholesterolemia cases with controls
    Samia Perwaiz Khan, Rubina Ghani, Khwaja Zafar Ahmed, Zia Yaqub · 2012 · International journal of collaborative research on internal medicine & public health
  46. Avaliação da medida do índice tornozelo-braquial em portadores de hipercolesterolemia familiar
    Programa de Cardiologia · 2013
  47. Familial Hypercholesterolemia: From Diagnosis to Treatment
    Elaheh Asadi, Ehsan Farashahi Yazd, Mohammad Hasan Sheikhha, Nasrin Ghasemi, Razieh Zarifian Yeganeh · 2014 · Iranian journal of diabetes and obesity
  48. Uso de estatinas durante
    Leopoldo Tapia Ceballos, B. Angelin, Clersida García · 2016
  49. Genetics of Lipid Disorders
    Marija Stojanova Jordanov · 2015 · Springer eBooks
  50. Avaliação da aterosclerose subclínica coronária, carotídea e rigidez aórtica em portadores de hipercolesterolemia familiar.
    São Paulo · 2008
  51. Associação das Doenças Arterial Periférica e Cardiovascular na Hipercolesterolemia Familiar Association of Peripheral Arterial and Cardiovascular Diseases in Familial Hypercholesterolemia
    Carolina Pereira, Marcio Hiroshi Miname, Marcia Regina Pinho Makdisse, Roberto Kalil Filho, Raul Dias Santos, São Paulo · 2014
  52. Children with familial hypercholesterolemia - a characterization of dietary intake and associations with blood lipid levels
    Kristin Torvik · 2014 · NORA - Norwegian Open Research Archives
  53. Klinische Sicherheit, Effektivität und Biokompatibilität der DALI Apherese mit modifizierter Antikoagulation im Vergleich zum Standardverfahren
    Gerhard Steinbeck · 2008
  54. Применение афереза липопротеидов при атеросклерозе и его осложнениях
    Maya S. Safarova, Olga I. Afanasieva · 2014 · Атеросклероз и дислипидемии
  55. Long term follow-up of patients with Familial Hypercholesterolemia after participation in clinical trials in childhood: an exploratory study
    Ida Halvorsen · 2014 · NORA - Norwegian Open Research Archives
  56. Advances in dyslipidemia
    Wilbert S. Aronow · 2013
  57. Panvascular Disease in Familial Hypercholesterolaemia Treated with Endovascular Simultaneous Bilateral Carotid Stenting
    Anand Alurkar · 2016 · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH
  58. The ESCAPE randomized clinical trial: 20-80 mg of Zokor (Simvastatin) in patients with familial hypercholesterolemia in ischemia heart disease. Part 1. Hypolipidemic efficacy, safety and tolerance
    Andrei V. Sussekov, M. Yu. Zubareva, Rozhkova Ta, Горнякова Наталья Бадриевна, E. Yu. Solov’eva, Tat'yana Valentinovna Balakhonova, Б. Д. Кулев, О. А. Погорелова, А. Н. Рогоза, С. А. Бойцов et al. · 2009 · Arterial’naya Gipertenziya (Arterial Hypertension)
  59. Avaliação da associação da gordura pericárdica medida pela tomografia computadorizada com a presença de aterosclerose coronária subclínica em pacientes com hipercolesterolemia familiar
    Leonardo Celeste Mangili · 2016
  60. Introduction to Genetics and Its Value in Cardiovascular Disease Diagnosis: Basic Concepts and the Example of Familial Hypercholesterolemia
    Fernando Civeira, José Carlos Rodríguez-Rey, Miguel Pocovı́ · 2009 · Revista Española de Cardiología
  61. Machine Learning Methods To Identify Hidden Phenotypes In The Electronic Health Record
    Brett K. Beaulieu‐Jones · 2017 · ScholarlyCommons (University of Pennsylvania)
  62. A Review of Pediatric Cardiovascular Risk Factors and Current Guidelines
    Deeksha Sarma, Lawrence M. Benedict, Achintya N. Moulick, Randy M. Stevens, Vicki L. Mahan · 2018 · World Journal of Cardiovascular Surgery
  63. Programa de seguimento de coorte de pacientes com hipercolesterolemia familiar na região metropolitana de São Paulo
    Pãmela Rodrigues de Souza Silva · 2018
  64. Result of Genetic Analysis in FH Case
    Gumpanart Veerakul, Chanin Limwongse, Michael David Shapiro, Sergio Fazio, ertlak Chaothawee, Narucha Chaishotiranant · 2018 · THE BANGKOK MEDICAL JOURNAL
  65. Molecular Screening of Familial Hypercholesterolemia in the Icelandic Population
    Greg Kellogg, Bolli Þórsson, Ying Cai, Robert G. Wisotzkey, Andrew Pollock, Matthew Akana, Rebecca Fox, Michael Jansen, Elias Freyr Gudmundsson, Bonny Patel et al. · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
  66. Um enfoque para componentes subjetivos na hipercolesterolemia familiar: avaliação e análise da qualidade de vida relacionada à saúde em face ao sentido de autoeficácia de pacientes inscritos no Programa Hipercol Brasil
    Ana Cristina Carneiro Fernandes Souto · 2018
  67. INNOVATIVE TECHNOLOGIES IN DIAGNOSIS AND TREATMENT OF EXTREME FAMILIAL HYPERCHOLESTEROLEMIA
    В. В. Симерзин, OV V Fatenkov, IV V Gagloeva, Галкина Мария Анатольевна, Ya. A. Panisheva, Сытдыков Ильнар Халитович · 2016 · Science and Innovations in Medicine
  68. Recent Advances in Therapeutic Approaches for Familial Hypercholesterolemia
    K.N. Arul Jothi · 2017 · Genomics & Gene Therapy International Journal
  69. The Pattern of Risk Factor Profile and Dutch Lipid Clinic Network Criteria of Familial Hypercholesterolemia in Egyptian Patients with Premature Coronary Heart Disease
    A.M.F. Ellaien, Ashraf Reda, Ahmed Elkersh · 2020 · Cardiology and Cardiovascular Research
  70. iPSCs for modeling familial hypercholesterolemia type II A
    Jérôme Caron, Anne Dubart‐Kupperschmitt, Anne Weber · 2020 · Elsevier eBooks
  71. Associação entre padrão dietético e parâmetros bioquímicos de indivíduos brasileiros e espanhóis com hipercolesterolemia familiar
    Luiza Antoniazzi Gomes de Gouveia · 2020
  72. O Risco Desconhecido de Hipercolesterolemia Familiar no Desenvolvimento de Doença Cardiovascular Aterosclerótica
    Elizabeth do Nascimento, José Luiz de Brito Alves · 2021 · Arquivos Brasileiros de Cardiologia
  73. The new Zealand
    Robin Smith Warren Jacbs, G. C. BILLING. · 2018
  74. Genetic Screening for Disease
    Lidewij Henneman, Daniëlle R. M. Timmermans · 2015 · Elsevier eBooks
  75. Monogenic Hypercholesterolemias
    Fernando Civeira, Miguel Pocovı́ · 2015 · Contemporary Endocrinology
  76. Familial hypercholesterolemia
    Shifa Jebari‐Benslaiman, Unai Galicia-García, A. Larrea, Kepa B. Uribe, César Martı́n, Asier Benito‐Vicente · 2022 · Elsevier eBooks
  77. ¿Hasta dónde hay que reducir el colesterol en el paciente de alto riesgo cardiovascular?
    P. Armario, R. Hernández del Rey, M.N. Görbig Romeu · 2005 · Hipertensión
  78. Hipercolesterolemias genéticas
    Ana Cenarro, Isabel de Castro-Orós, Fernando Civeira Murillo · 2013 · Medicine - Programa de Formación Médica Continuada Acreditado
  79. Lipid metabolism
    Ian Stuart Young, D. P. Nicholls · 2004 · Current Opinion in Lipidology
  80. Risk Factors Affecting the Phenotypic Expression of Heterozygous Familial Hypercholesterolemia in Pakistani Population
    Fauzia Imtiaz · 2010 · Atlas Journal of Biology
  81. Efficacy and safety of Mertenil (rosuvastatin) 40 mg in patients with familial hypercholesterolemia
    M. Zubareva, Малышев Павел Прокопьевич, Rozhkova Ta, V V Kuharchuk · 2014 · Systemic Hypertension
  82. Spectrum of Cardiovascular Manifestations in Homozygous Familial Hypercholesterolemia
    Nitin Bajaj, Balbir Bagicha Singh, Ananthkrishnan Ramamoorthy, Arijit Kumar Ghosh · 2022 · Journal of Marine Medical Society
  83. Análise dos genes STAP1, APOE, ABCG5 e ABCG8 em pacientes hipercolesterolêmicos com diagnóstico molecular negativo para os genes LDLR, APOB e PCSK9
    Maurício Teruo Tada · 2022
  84. Caracterização de indivíduos idosos portadores de hipercolesterolemia familiar
    Elaine dos Reis Coutinho · 2022
  85. Edukasi Mengenai Makanan Sehat untuk Menanggulangi Hiperkolesterolemia pada Masyarakat Desa Cikupa
    Belinda Layrenshia, Zita Atzmardina · 2024 · Syntax Literate Jurnal Ilmiah Indonesia
  86. Hypercholesterolemia Familial: Early Cardiovascular Complications, Treatment Challenges, and the Fatal Consequences of Delayed Diagnosis: an in-Depth Case Study
    Mina Boutgourine, Hafssa Rouam, Mohammed El Jamili, Mustapha El Hattaoui · 2024 · Cardiology and Angiology An International Journal
  87. Rapid lipid-lowering response in two cases of autosomal recessive hypercholesterolemia
    Havva Yazıcı, Fehime Erdem, Ebru Erbaş Canda, Sema Kalkan Uçar, Mahmut Çöker · 2024 · Journal of clinical lipidology
  88. Familial hypercholesterolemia with alt elevation: a case report
    Hannah K Olle · 2025 · Endocrinology&Metabolism International Journal
  89. Me viene de familia
    Lucía Molina Campos, Jorge Díaz Piñeiro, Jose María Casado Viñas · 2022 · Actualización en Medicina de Familia
  90. Additional file 1 of Current causes of death in familial hypercholesterolemia
    Victoria Marco-Benedí, Ana M. Bea, Ana Cenarro, Estíbaliz Jarauta, Laclaustra, Martín, Fernando Civeira · 2022 · Figshare
  91. Additional file 2 of Current causes of death in familial hypercholesterolemia
    Victoria Marco-Benedí, Ana M. Bea, Ana Cenarro, Estíbaliz Jarauta, Laclaustra, Martín, Fernando Civeira · 2022 · Figshare
  92. Lipidemic Profile of Patients with Non-Small Cell Lung Cancer and Its Association with Driver Mutations: A Tertiary Center Retrospective Study
    Maria Lagadinou, Dimitrios Efthymiou, Fotios Sampsonas, Prokopis Karidis, Ioanna Marlafeka, Eirini Adamopoulou, Christos Michailides, Pinelopi Bosgana, Ουρανία Παπαϊωάννου, Emmanouil Psarros et al. · 2026 · Cancers
  93. The High Price of Interrupted Follow‐Up: Catastrophic Progression of Homozygous Familial Hypercholesterolemia—A Case Report and Literature Review
    Parham Dastjerdi, Mahdieh Aghababaei, Reza Nikfar, Maryam Aghakouchakzadeh, Reza Mohseni Badalabadi, Kaveh Hosseini · 2026 · Clinical Case Reports
  94. Clinical characteristics and lipid management of patients with familial hypercholesterolemia: results from a 7 years single-centre experience
    Amber Vanhulle, Dilara Yurdaer, Lynn Van Calster, Anne‐Marie Willems, Veronique Moerman, J De Sutter · 2026 · Acta Clinica Belgica
  95. Hépatocytes différenciés à partir de cellules souches pluripotentes : un modèle d’études physiopathologiques et de thérapie génique et cellulaire - Application à l'hypercholestérolémie familiale de type IIA
    Jérôme Caron · 2017 · theses.fr (ABES)
  96. Metabolic homeostasis and regulatory mechanisms of cellular senescence : roles of ITPR2-mediated calcium fluxes and mevalonate pathway
    Dorian V. Ziegler · 2020